Xavier Billot
Impact in
- Biotechnology top 10%
- Marine Sponges and Natural Products
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
- Microbial Natural Products and Biosynthesis
Papers in
-
- Cell death mechanisms and regulation 2
- Chemical Synthesis and Analysis 2
- Ubiquitin and proteasome pathways 2
-
- Chemical synthesis and alkaloids 1
- Synthetic Organic Chemistry Methods 1
- Co-authors
- Leonie A. Cluse (1 shared paper)Richard Marcellus (2 shared papers)S.R. Murthy Madiraju (1 shared paper)Pierre Beauparlant (3 shared papers)Stéphane Acoca (2 shared papers)Anne Roulston (3 shared papers)Gordon C. Shore (3 shared papers)Jean Viallet (1 shared paper)
In The Last Decade
Xavier Billot
10 papers receiving 756 citations
Xavier Billot's Hit Papers
Peers
Comparison fields: 5 of 74
- Biotechnology 93
- Pharmacology 117
- Molecular Biology 463
- Genetics 71
- Toxicology 21
Countries citing papers authored by Xavier Billot
This map shows the geographic impact of Xavier Billot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Billot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Billot more than expected).
Fields of papers citing papers by Xavier Billot
This network shows the impact of papers produced by Xavier Billot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Billot. The network helps show where Xavier Billot may publish in the future.
Co-authors
The 25 scholars most cited alongside Xavier Billot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis Hit paper breakdown → | 2007 | 538 |
| 2 | 1998 | 74 | |
| 3 | 2003 | 68 | |
| 4 | 2004 | 43 | |
| 5 | 2007 | 19 | |
| 6 | 2016 | 10 | |
| 7 | 2021 | 6 | |
| 8 | 2016 | 5 | |
| 9 | 2006 | 4 | |
| 10 | GMX1777: a novel inhibitor of NAD+ biosynthesis via inhibition of nicotinamide phosphoribosyl transferase. | 2007 | 2 |
About Xavier Billot
Xavier Billot is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 10 papers that have together received 769 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (2 papers), Chemical Synthesis and Analysis (2 papers), Ubiquitin and proteasome pathways (2 papers), Marine Sponges and Natural Products (2 papers), Inflammatory mediators and NSAID effects (2 papers), Chemical synthesis and alkaloids (1 paper), Mast cells and histamine (1 paper) and Synthetic Organic Chemistry Methods (1 paper). The work is most often cited by research in Biotechnology (93 citations), Pharmacology (117 citations), Molecular Biology (463 citations), Genetics (71 citations) and Toxicology (21 citations). Xavier Billot has collaborated with scholars based in Canada, France and Australia. Frequent co-authors include Leonie A. Cluse, Richard Marcellus, S.R. Murthy Madiraju, Pierre Beauparlant, Stéphane Acoca, Anne Roulston, Gordon C. Shore, Jean Viallet, Ricky W. Johnstone and Lucile Serfass. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Molecular Cancer Therapeutics, Journal of the American Chemical Society and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.